Down syndrome and acute myeloid leukemia. Lessons learned from experience with high-dose Ara-C containing regimens

Adv Exp Med Biol. 1999:457:409-14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Cytarabine / administration & dosage
  • Cytarabine / pharmacokinetics
  • Cytarabine / therapeutic use*
  • Deoxycytosine Nucleotides / metabolism
  • Disease-Free Survival
  • Dose-Response Relationship, Drug
  • Down Syndrome / complications*
  • Humans
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / epidemiology

Substances

  • Deoxycytosine Nucleotides
  • Cytarabine
  • 2'-deoxycytidine 5'-triphosphate